Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion type Assertion NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_head.
- NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion description "[In the current study, low-abundance nuclear proteins were enriched for proteomic analysis by using a state-of-the-art two-dimensional differential gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) strategy to compare and identify the nuclear protein profiling changes responsible for the development of doxorubicin resistance in human uterine cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_provenance.
- NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion evidence source_evidence_literature NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_provenance.
- NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion SIO_000772 24675091 NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_provenance.
- NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion wasDerivedFrom befree-20150227 NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_provenance.
- NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_assertion wasGeneratedBy ECO_0000203 NP829012.RARSZYgVdEt9aFC_5d8dMLgatkcZmc8Uhud8kefMue8A8130_provenance.